Personalized medicine is becoming a major theme in fibrotic disease treatment. Fibrosis can progress differently across patients, making it important for clinicians and researchers to understand individual disease characteristics, risk factors, and treatment response. Biomarkers may help identify disease activity, estimate progression risk, monitor treatment effects, and support clinical trial...